Compare Novo Nordisk A/S (NVO) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Symbotic Inc — how do they compare? Novo Nordisk A/S trades at $45.95 (market cap $207.85B), while Symbotic Inc trades at $42 (market cap $5.41B). The key difference: Novo Nordisk A/S is far larger — about 38.4× Symbotic Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| NVO | SYM | |
|---|---|---|
Market Cap | $207.85B | $5.41B |
Sector | Health | Technology |
52-Week High | $63.98 | $87.30 |
52-Week Low | $35.29 | $38.57 |
Enterprise Value | $222.55B | $3.67B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
